That is not what I'm trying to do, Madam Chair. I'm simply trying to wrap my head around this issue. The word “flexibility“ has been mentioned and I'm hearing that the guidelines in the regulations will provide for more flexibility that the elements set out in subparagraph (c)(ii) where mention is made of “a signed document certifying that the activity is conducted in accordance with the Laboratory Biosafety Guidelines“.
If I go by what Ms. Alain is saying, I have to conclude that the laboratory biosafety guidelines are too stringent regarding risk group 2 pathogens. My understanding is that in the case of risk group 2 pathogens, these guidelines will not be applied in the same way as they are for risk group 3 and 4 substances. Am I correct?